Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 1.00 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.62 |
| ▸ | FDPS | P14324 | 3/20 | 0.60 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11133953 | 0.98 | SIGMAR1 (0.96) | SIGMAR1AOC3FDPSGGPS1KCNH2 | |
| SCHEMBL7371550 | 0.94 | SIGMAR1 (1.00) | SIGMAR1FDPSGGPS1KCNH2 | |
| SCHEMBL12902332 | 0.94 | SIGMAR1 (0.88) | SIGMAR1AOC3FDPSKCNH2SLC6A2 | |
| SCHEMBL11134428 | 0.92 | SIGMAR1 (0.96) | SIGMAR1AOC3FDPSGGPS1SLC6A2 | |
| SCHEMBL29107028 | 0.90 | SIGMAR1 (0.82) | SIGMAR1AOC3KCNH2SLC6A2SLC6A4 | |
| SCHEMBL11131202 | 0.90 | SIGMAR1 (0.82) | SIGMAR1AOC3KCNH2SLC6A2SLC6A4 | |
| SCHEMBL19253990 | 0.90 | SIGMAR1 (0.86) | SIGMAR1FDPSGGPS1KCNH2 | |
| SCHEMBL8092655 | 0.90 | SIGMAR1 (1.00) | SIGMAR1FDPSGGPS1KCNH2SLC6A2 | |
| SCHEMBL11130673 | 0.90 | SIGMAR1 (0.86) | SIGMAR1FDPSGGPS1KCNH2 | |
| SCHEMBL11567562 | 0.90 | SIGMAR1 (0.86) | SIGMAR1FDPSGGPS1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6057371-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-05-02 | — | — | US | claimed |
| EP-0591426-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1994-04-13 | — | — | EP | claimed |
| WO-1993000313-A2 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1993-01-07 | — | — | WO | claimed |
| US-6057371-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0591426-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1994-04-13 | — | — | EP | disclosed |
| WO-1993000313-A2 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1993-01-07 | — | — | WO | disclosed |